» Articles » PMID: 35326536

Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and Neck

Abstract

Adenoid cystic carcinoma (ACC) is a rare malignancy in the head and neck. The prognosis remains poor and late recurrences often occur after 5 years and later. To date, there are no reliable prognostic markers for ACC. In several solid tumors, tertiary lymphoid structures (TLS) are associated with improved survival. This study aims to investigate the role of distribution patterns of tumor infiltrating immune cells (TIL) in ACC. A cohort of 50 patients from three different cancer centers was available for analysis. Sections were stained for CD3, CD4, CD8 and CD20 and evaluated with regard to their distribution of TIL. Patterns were determined as infiltrated-excluded, infiltrated-inflamed and presence of tertiary lymphoid structures. About half of the cases showed an infiltrated-excluded TIL pattern and only a minority of six cases had TLS present within the tumor. Within the inflamed phenotype CD3+ cells were by far the most abundant lymphocyte subtype, and within this compartment, CD8+ T cells were predominant. There was no influence on overall or disease-free survival by any of the TIL patterns. This indicates that ACC is a tumor with very low immunogenicity and even abundance of lymphocytes does not seem to improve prognosis for this disease. Therefore, the observed lack of response towards immunotherapy is not surprising and other methods to induce recognition of ACC by the immune system must be found.

Citing Articles

Heterogeneous immune landscapes and macrophage dynamics in primary and lung metastatic adenoid cystic carcinoma of the head and neck.

Wang X, Ma T, Liu H, Zhang S, Yang G, Zhao Y Front Immunol. 2024; 15:1483887.

PMID: 39697346 PMC: 11653016. DOI: 10.3389/fimmu.2024.1483887.


Stroma-and Tumor-Associated Predictive Features in Salivary Gland Adenoid Cystic Carcinoma of the Head and Neck.

Rytkonen A, Laine H, Makitie A, Haglund C, Hagstrom J, Almangush A J Oral Pathol Med. 2024; 54(1):22-30.

PMID: 39523633 PMC: 11730399. DOI: 10.1111/jop.13589.


CD3 and CD20 Expressions and Infiltrating Patterns in Salivary Gland Tumors.

Hussein R, Garib B Diagnostics (Basel). 2024; 14(9).

PMID: 38732373 PMC: 11082958. DOI: 10.3390/diagnostics14090959.


Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort.

Zupancic M, Nasman A, Berglund A, Dalianis T, Friesland S Cancers (Basel). 2023; 15(5).

PMID: 36900288 PMC: 10000643. DOI: 10.3390/cancers15051499.

References
1.
Lloyd S, Yu J, Wilson L, Decker R . Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol. 2010; 34(1):76-81. DOI: 10.1097/COC.0b013e3181d26d45. View

2.
SPIRO R, Huvos A, Strong E . Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. Am J Surg. 1974; 128(4):512-20. DOI: 10.1016/0002-9610(74)90265-7. View

3.
Clarke J, Panwar B, Madrigal A, Singh D, Gujar R, Wood O . Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer. J Exp Med. 2019; 216(9):2128-2149. PMC: 6719422. DOI: 10.1084/jem.20190249. View

4.
Germain C, Devi-Marulkar P, Knockaert S, Biton J, Kaplon H, Letaief L . Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients. Front Immunol. 2021; 12:626776. PMC: 7983944. DOI: 10.3389/fimmu.2021.626776. View

5.
Wang K, Shen T, Siegal G, Wei S . The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer. Hum Pathol. 2017; 69:110-117. DOI: 10.1016/j.humpath.2017.09.012. View